Company Filing History:
Years Active: 2012
Title: Eric C Anderson: Innovator in CCR9 Receptor Modulation
Introduction
Eric C Anderson is a notable inventor based in Irving, TX (US). He has made significant contributions to the field of biochemistry, particularly in the modulation of the CCR9 receptor. His work has implications for treating various diseases associated with this receptor.
Latest Patents
Eric holds a patent titled "Modulators of CCR9 receptor and methods of use thereof." This patent includes compounds that act as modulators of CCR9 receptor activity, along with compositions containing these compounds. The methods described in the patent focus on treating or ameliorating diseases linked to the modulation of CCR9 receptor activity.
Career Highlights
Eric is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His role involves research and development in innovative therapeutic solutions. His expertise in receptor modulation has positioned him as a key player in advancing medical treatments.
Collaborations
Throughout his career, Eric has collaborated with esteemed colleagues, including Ronald J Biediger and Jie Chen. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Eric C Anderson's contributions to the field of receptor modulation exemplify the impact of innovative research in medicine. His work continues to pave the way for new therapeutic approaches to treat diseases associated with CCR9 receptor activity.